1.- Thompson DF: "Understanding financial conflicts of interest". New Engl J Med, 329(1993),573-576.
2.- Korenman SG: "Conflicts of interest and commercialization of research". Acad Med, 68(Suppl.3)(1993),S18-S22.
3.- Sykes R: "Innovation in the pharmaceutical industry". BMJ, 309(1994), 422-3.
4.- "American Federation for Clinical Research guidelines for avoiding conflict of interest". J Clin Res, 38(1990), 239-240.
5.- Mervis J: "Final rules put Universities in charge". Science, 269(1995), 294.
6.- Witt MD, Gostin LO: "Conflict of interest dilemmas in biomedical research". JAMA, 271(1994), 547-551.
7.- Relman AS: "Economic incentives in clinical investigation". New Engl J Med, 320(1989), 933-934.
8.- "PHS Grants Policy Satement, Revised". Washington, DC: US Public Health Service 1991. Dept. of Health and Human Services publication 82-50,000. (Véase el texto ulterior publicado oficialmente en el Federal Register de 11 de julio de 1995)
9.- "Request for comment on proposed guidelines for policies on conflicts of interest. NIH Guide to Grants and Contracts". Bethesda, MD:National Institutes of Health 1989;18(No.32):3-4. (La versión oficial corregida ha sido publicada en el Federal Register de 28 de junio de 1994)
10.- Harvard University, Faculty of Medicine. "Policy on conflicts of interest and commitment". Boston: Harvard Medical School, March 22, 1990.
11.- Council on Scientific Affairs and Council on Ethical and Judicial Affairs. American Medical Association." Conflicts of interest in medical center/industry research relationships". JAMA, 263(1990), 2790-2793.
12.- Guidelines for dealing with faculty conflicts of commitment and conflicts onf interest in research. Acad Med, 65(1990), 485-495.
13.- Gunsalus CK: "Institutional structure to ensure research integrity". Acad Med, 68(Suppl.3)(1993), S33-S38.
14.- International Committee of Medical Journal Editors: "Conflict of interest". Lancet, 341(1993), 742-743.
15.- Smith R: "Conflict of interest and the BMJ". BMJ, 308(1994), 4-5.
16.- Shimm DS, Spece RG: "Ethical issues and clinical trials". Drugs, 46(1993), 579-584.
17.- La Puma J, Stocking CB, Rhoades WD, Darling CM: " Financial ties as part of informed consent to posmarketing research. Attitudes of american doctors and patients". BMJ, 310(1995), 1660-1663.
18.- Stamler J: "Effective clinical trials investigators and adequate incentives". Clin Pharmacol Ther, 25(1979), 666-670.
19.- Ministerio de Sanidad y Consumo. "Real Decreto 561/1993, de 16 de abril, por el que se establecen los requisitos para la realización de ensayos clínicos con medicamentos". BOE de 13 de mayo de 1993;114:14346-64
20.- Rothman KJ: "Conflict of interest. The new McCarthyism in science". JAMA, 269(1993), 2782-2784.